GlobeMed recognizes the importance of spreading awareness about prevention & early detection to halt the spread of cancer. As part of these efforts, GlobeMed has finalized an exhaustive research about cancer in Egypt based on its experience and the information available to GlobeMed Egypt at the date of this study.
The study, with data covering 6 years from 2014 to 2019 on GlobeMed Egypt’s portfolio, revealed notable findings, mainly:
- Cancer incidence rates are increasing with an overall average annual increase of 6.5%, averaging around 362 new cancer cases per 100,000 persons.
- Around 20% of all new cancer cases occur in the blood and lymphatic system, followed by the digestive system and breast at about 17% each. Those three locations account for more than 54% of all cancer cases under GlobeMed Egypt experience.
Female population
Breast cancer is the leading type of cancer in women and overall representing 1 in every 6 cases. Leukemia comes in second place followed by lymphoma, colon cancer, brain & nervous system.
Male population
Leukemia tops the list of most likely to occur below 40 years of age, while colon and prostate cancers top the list after the age of 60. Other types of cancer are in the lymphatic system, the brain and the nervous system appearing in males between 20 & 50 years of age.
This study shows that the increase in cancer cases might be due to the increase in the early detection tests as a result of increased awareness programs about cancer.
Thanks to advances in medical research, remarkable progress is being made against cancer. However, the study is a clear reminder that more effort is needed under prevention and early detection of cancer which significantly increases survival rates and at the same time reduces treatment costs.
To read the full bulletin, please visit GlobeMed Egypt website www.globemedegypt.com
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
